These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30864836)

  • 21. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
    Lee SH; Ha S; An HJ; Lee JS; Han W; Im SA; Ryu HS; Kim WH; Chang JM; Cho N; Moon WK; Cheon GJ
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1574-84. PubMed ID: 27209424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
    Roberts MC; Miller DP; Shak S; Petkov VI
    Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research on the cutoff tumor size of omitting radiotherapy for BCSS after breast conserving surgery in women aged 65 years or oder with low-risk invasive breast carcinoma: Results based on the SEER database.
    Yang Z; Li K; Qiu P; Ma Y; Wang B; Yan Y; Meng D; Feng C; Ren Y; Li Y; Li P; Zhou C
    Breast; 2021 Dec; 60():287-294. PubMed ID: 34844175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omission of adjuvant radiotherapy following breast-conserving surgery for elderly women with early-stage pure mucinous breast carcinoma.
    Wu SG; Li FY; Wang J; Lian CL; Zhou J; He ZY
    Radiat Oncol; 2019 Nov; 14(1):190. PubMed ID: 31685005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT.
    Killander F; Karlsson P; Anderson H; Mattsson J; Holmberg E; Lundstedt D; Holmberg L; Malmström P
    Eur J Cancer; 2016 Nov; 67():57-65. PubMed ID: 27614164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.
    Choi SH; Kim JW; Choi J; Sohn J; Kim SI; Park S; Park HS; Jeong J; Suh CO; Keum KC; Kim YB; Lee IJ
    Clin Breast Cancer; 2018 Apr; 18(2):e167-e178. PubMed ID: 28689012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
    Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
    Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of care with regard to surgical choice and application of adjuvant radiation therapy for preinvasive and early stage breast cancer in rural Appalachia.
    Freeman AB; Huang B; Dragun AE
    Am J Clin Oncol; 2012 Aug; 35(4):358-63. PubMed ID: 21422902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery.
    Wu SG; Zhang WW; Wang J; Dong Y; Sun JY; Chen YX; He ZY
    Front Oncol; 2019; 9():1. PubMed ID: 30761267
    [No Abstract]   [Full Text] [Related]  

  • 31. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
    Dinan MA; Mi X; Reed SD; Lyman GH; Curtis LH
    JAMA Oncol; 2015 Nov; 1(8):1098-109. PubMed ID: 26313372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
    Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
    JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival.
    Poleszczuk J; Luddy K; Chen L; Lee JK; Harrison LB; Czerniecki BJ; Soliman H; Enderling H
    Breast Cancer Res; 2017 Jun; 19(1):75. PubMed ID: 28666457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    Ann Surg Oncol; 2015 Nov; 22(12):3836-45. PubMed ID: 25743325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
    Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
    Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
    Iwata H; Masuda N; Yamamoto Y; Fujisawa T; Toyama T; Kashiwaba M; Ohtani S; Taira N; Sakai T; Hasegawa Y; Nakamura R; Akabane H; Shibahara Y; Sasano H; Yamaguchi T; Sakamaki K; Bailey H; Cherbavaz DB; Jakubowski DM; Sugiyama N; Chao C; Ohashi Y
    Breast Cancer Res Treat; 2019 Jan; 173(1):123-133. PubMed ID: 30242578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.